Algert Global LLC Regenxbio Inc. Transaction History

Algert Global LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $231,891 - $374,551	17,990 New	17,990 $323,000
Q2 2022 Aug 15, 2022	SELL	$19.35 - $35.04 $214,262 - $387,997	-11,073 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$24.62 - $34.31 $272,617 - $379,914	11,073 New	11,073 $368,000
Q1 2021 May 14, 2021	SELL	$33.61 - $49.95 $1.01 Million - $1.5 Million	-30,124 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$26.52 - $49.35 $300,816 - $559,777	11,343 Added 60.4%	30,124 $1.37 Million
Q3 2020 Nov 16, 2020	BUY	$27.01 - $40.26 $507,274 - $756,123	18,781 New	18,781 $517,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $439M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.